ARRY
Price
$6.68
Change
-$0.27 (-3.88%)
Updated
Jul 24 closing price
Capitalization
2.22B
13 days until earnings call
IBRX
Price
$3.01
Change
+$0.02 (+0.67%)
Updated
Jul 24 closing price
Capitalization
2.66B
12 days until earnings call
Interact to see
Advertisement

ARRY vs IBRX

Header iconARRY vs IBRX Comparison
Open Charts ARRY vs IBRXBanner chart's image
Array Technologies
Price$6.68
Change-$0.27 (-3.88%)
Volume$3.44M
Capitalization2.22B
ImmunityBio
Price$3.01
Change+$0.02 (+0.67%)
Volume$7.27M
Capitalization2.66B
ARRY vs IBRX Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. IBRX commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a StrongBuy and IBRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (IBRX: $3.01)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBRX’s FA Score shows that 1 FA rating(s) are green while.

  • IBRX’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while IBRX’s TA Score has 5 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 5 bearish.
  • IBRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IBRX is a better buy in the short-term than ARRY.

Price Growth

IBRX (@Biotechnology) experienced а +6.36% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.05%. For the same industry, the average monthly price growth was +18.11%, and the average quarterly price growth was +28.55%.

Reported Earning Dates

IBRX is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+6.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.66B) has a higher market cap than ARRY($2.22B). IBRX YTD gains are higher at: 17.578 vs. ARRY (10.596). ARRY has higher annual earnings (EBITDA): 276M vs. IBRX (-264M). ARRY has more cash in the bank: 249M vs. IBRX (61.6M). IBRX has less debt than ARRY: IBRX (526M) vs ARRY (730M). ARRY has higher revenues than IBRX: ARRY (1.58B) vs IBRX (31.2M).
ARRYIBRXARRY / IBRX
Capitalization2.22B2.66B84%
EBITDA276M-264M-105%
Gain YTD10.59617.57860%
P/E Ratio26.23N/A-
Revenue1.58B31.2M5,054%
Total Cash249M61.6M404%
Total Debt730M526M139%
FUNDAMENTALS RATINGS
ARRY vs IBRX: Fundamental Ratings
ARRY
IBRX
OUTLOOK RATING
1..100
549
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5359
P/E GROWTH RATING
1..100
29100
SEASONALITY SCORE
1..100
70n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBRX's Valuation (4) in the Biotechnology industry is significantly better than the same rating for ARRY (89). This means that IBRX’s stock grew significantly faster than ARRY’s over the last 12 months.

IBRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that IBRX’s stock grew similarly to ARRY’s over the last 12 months.

IBRX's SMR Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that IBRX’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's Price Growth Rating (53) in the Biotechnology industry is in the same range as IBRX (59). This means that ARRY’s stock grew similarly to IBRX’s over the last 12 months.

ARRY's P/E Growth Rating (29) in the Biotechnology industry is significantly better than the same rating for IBRX (100). This means that ARRY’s stock grew significantly faster than IBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYIBRX
RSI
ODDS (%)
Bullish Trend 26 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 19 days ago
79%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LCCAX38.35N/A
N/A
Columbia Contrarian Core A
CSVZX38.63N/A
N/A
Columbia Select Large Cap Value Inst
KCVIX18.12N/A
N/A
Knights of Columbus Large Cap Value I
PEDMX13.38N/A
N/A
Principal Edge MidCap R6
UGTIX28.36N/A
N/A
Victory Growth and Tax Strategy Ins